Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.

Wu J, Lubman DM, Kugathasan S, Denson LA, Hyams JS, Dubinsky MC, Griffiths AM, Baldassano RN, Noe JD, Rabizadeh S, Gulati AS, Rosh JR, Crandall WV, Higgins PDR, Stidham RW.

Am J Gastroenterol. 2019 May;114(5):777-785. doi: 10.14309/ajg.0000000000000237.

PMID:
31058681
2.

A Method for Isolation and Proteomic Analysis of Outer Membrane Vesicles from Fecal Samples by LC-MS/MS.

Wu J, An M, Zhu J, Tan Z, Chen GY, Stidham RW, Lubman DM.

J Proteomics Bioinform. 2019;12(2):38-42. doi: 10.4172/0974-276X.1000494. Epub 2019 Mar 18.

PMID:
31057293
3.

Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.

Zhu J, Warner E, Parikh ND, Lubman DM.

Mass Spectrom Rev. 2019 May;38(3):265-290. doi: 10.1002/mas.21583. Epub 2018 Nov 25. Review.

PMID:
30472795
4.

Single Amino Acid Variant Discovery in Small Numbers of Cells.

Tan Z, Yi X, Carruthers NJ, Stemmer PM, Lubman DM.

J Proteome Res. 2019 Jan 4;18(1):417-425. doi: 10.1021/acs.jproteome.8b00694. Epub 2018 Nov 21.

PMID:
30404448
5.

Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.

Zhu J, Chen Z, Zhang J, An M, Wu J, Yu Q, Skilton SJ, Bern M, Ilker Sen K, Li L, Lubman DM.

J Proteome Res. 2019 Jan 4;18(1):359-371. doi: 10.1021/acs.jproteome.8b00654. Epub 2018 Oct 29.

PMID:
30370771
6.

Comparison of an Optimized Ultracentrifugation Method versus Size-Exclusion Chromatography for Isolation of Exosomes from Human Serum.

An M, Wu J, Zhu J, Lubman DM.

J Proteome Res. 2018 Oct 5;17(10):3599-3605. doi: 10.1021/acs.jproteome.8b00479. Epub 2018 Sep 19.

PMID:
30192545
7.

Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey.

Wang M, Zhu J, Lubman DM, Gao C.

Clin Chem Lab Med. 2019 Mar 26;57(4):407-416. doi: 10.1515/cclm-2018-0379. Review.

8.

High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome Metabolomics.

Luo X, An M, Cuneo KC, Lubman DM, Li L.

Anal Chem. 2018 Jul 17;90(14):8314-8319. doi: 10.1021/acs.analchem.8b01726. Epub 2018 Jul 3.

PMID:
29920066
9.

Circulating Microvesicles from Pancreatic Cancer Accelerate the Migration and Proliferation of PANC-1 Cells.

An M, Zhu J, Wu J, Cuneo KC, Lubman DM.

J Proteome Res. 2018 Apr 6;17(4):1690-1699. doi: 10.1021/acs.jproteome.8b00014. Epub 2018 Mar 9.

10.

The analysis of alpha-1-antitrypsin glycosylation with direct LC-MS/MS.

Yin H, An M, So PK, Wong MY, Lubman DM, Yao Z.

Electrophoresis. 2018 Sep;39(18):2351-2361. doi: 10.1002/elps.201700426. Epub 2018 Feb 26.

PMID:
29405331
11.

LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.

Huang Y, Zhou S, Zhu J, Lubman DM, Mechref Y.

Electrophoresis. 2017 Sep;38(17):2160-2167. doi: 10.1002/elps.201700025. Epub 2017 Jul 14.

12.

Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer.

Yang R, Liu X, Thakolwiboon S, Zhu J, Pei X, An M, Tan Z, Lubman DM.

J Proteomics Bioinform. 2016 Oct;9(10):238-247. doi: 10.4172/jpb.1000412. Epub 2016 Oct 3.

13.

Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.

Zhu J, Wu J, Pei X, Tan Z, Shi J, Lubman DM.

PLoS One. 2017 Apr 3;12(4):e0175039. doi: 10.1371/journal.pone.0175039. eCollection 2017.

14.

Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy.

An M, Lohse I, Tan Z, Zhu J, Wu J, Kurapati H, Morgan MA, Lawrence TS, Cuneo KC, Lubman DM.

J Proteome Res. 2017 Apr 7;16(4):1763-1772. doi: 10.1021/acs.jproteome.7b00024. Epub 2017 Mar 8.

15.

Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease.

Stidham RW, Wu J, Shi J, Lubman DM, Higgins PD.

PLoS One. 2017 Jan 23;12(1):e0170506. doi: 10.1371/journal.pone.0170506. eCollection 2017.

16.

Single Amino Acid Variant Profiles of Subpopulations in the MCF-7 Breast Cancer Cell Line.

Tan Z, Nie S, McDermott SP, Wicha MS, Lubman DM.

J Proteome Res. 2017 Feb 3;16(2):842-851. doi: 10.1021/acs.jproteome.6b00824. Epub 2017 Jan 20.

17.

Development of an Integrated Pipeline for Profiling Microbial Proteins from Mouse Fecal Samples by LC-MS/MS.

Wu J, Zhu J, Yin H, Liu X, An M, Pudlo NA, Martens EC, Chen GY, Lubman DM.

J Proteome Res. 2016 Oct 7;15(10):3635-3642. Epub 2016 Sep 2.

18.

Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.

Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, Umar A, Srivastava S, Steele VE, Rinaudo JA.

Pancreas. 2016 Sep;45(8):1080-91. doi: 10.1097/MPA.0000000000000705.

19.

A procedure for the analysis of site-specific and structure-specific fucosylation in alpha-1-antitrypsin.

Yin H, Zhu J, Wu J, Tan Z, An M, Zhou S, Mechref Y, Lubman DM.

Electrophoresis. 2016 Oct;37(20):2624-2632. doi: 10.1002/elps.201600176. Epub 2016 Sep 5.

20.

CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias.

Pei X, Zhu J, Yang R, Tan Z, An M, Shi J, Lubman DM.

PLoS One. 2016 Jun 22;11(6):e0158021. doi: 10.1371/journal.pone.0158021. eCollection 2016. Erratum in: PLoS One. 2017 Apr 25;12 (4):e0176804.

21.

ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.

Zhang Y, Zhu J, Yin H, Marrero J, Zhang XX, Lubman DM.

J Proteome Res. 2015 Dec 4;14(12):5388-95. doi: 10.1021/acs.jproteome.5b00792. Epub 2015 Nov 3.

22.

Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.

Zhu J, Wu J, Yin H, Marrero J, Lubman DM.

J Proteome Res. 2015 Nov 6;14(11):4932-9. doi: 10.1021/acs.jproteome.5b00662. Epub 2015 Oct 13.

23.

Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma.

Yin H, Tan Z, Wu J, Zhu J, Shedden KA, Marrero J, Lubman DM.

J Proteome Res. 2015 Nov 6;14(11):4876-84. doi: 10.1021/acs.jproteome.5b00718. Epub 2015 Oct 2.

24.

A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations.

Nie S, McDermott SP, Deol Y, Tan Z, Wicha MS, Lubman DM.

Proteomics. 2015 Nov;15(22):3772-83. doi: 10.1002/pmic.201500002. Epub 2015 Oct 7.

25.

Exosome enrichment of human serum using multiple cycles of centrifugation.

Kim J, Tan Z, Lubman DM.

Electrophoresis. 2015 Sep;36(17):2017-26. doi: 10.1002/elps.201500131. Epub 2015 Jul 15.

26.

Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study.

Wu J, Yin H, Zhu J, Buckanovich RJ, Thorpe JD, Dai J, Urban N, Lubman DM.

PLoS One. 2015 Mar 23;10(3):e0121112. doi: 10.1371/journal.pone.0121112. eCollection 2015.

27.

Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry.

Tan Z, Yin H, Nie S, Lin Z, Zhu J, Ruffin MT, Anderson MA, Simeone DM, Lubman DM.

J Proteome Res. 2015 Apr 3;14(4):1968-78. doi: 10.1021/acs.jproteome.5b00068. Epub 2015 Mar 9.

28.

Heterogeneity of The CD90+ Population in Different Stages of Hepatocarcinogenesis.

Thakolwiboon S, Zhu J, Liang Q, Welling TH, Zhang M, Lubman DM.

J Proteomics Bioinform. 2014 Sep 12;7(10):296-302.

29.

Proteomics Characterization of Primary Human Oral Epithelial Cells Using a Novel Culture Technique for Use in Tissue Regeneration.

Kato H, Lo A, Kuo S, Nie S, Marcelo CL, Lubman DM, Feinberg SE.

MOJ Proteom Bioinform. 2015;2(4). pii: 52. Epub 2015 Aug 12.

30.

Overexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironment.

Zhu J, Thakolwiboon S, Liu X, Zhang M, Lubman DM.

PLoS One. 2014 Dec 23;9(12):e115507. doi: 10.1371/journal.pone.0115507. eCollection 2014.

31.

Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.

Nie S, Gurrea M, Zhu J, Thakolwiboon S, Heth JA, Muraszko KM, Fan X, Lubman DM.

J Proteome Res. 2015 Feb 6;14(2):814-22. doi: 10.1021/pr5008653. Epub 2014 Dec 12.

32.

Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.

Nie S, Yin H, Tan Z, Anderson MA, Ruffin MT, Simeone DM, Lubman DM.

J Proteome Res. 2014 Dec 5;13(12):6058-66. doi: 10.1021/pr500934u. Epub 2014 Nov 24.

33.

Insight into PreImplantation Factor (PIF*) mechanism for embryo protection and development: target oxidative stress and protein misfolding (PDI and HSP) through essential RIKP [corrected] binding site.

Barnea ER, Lubman DM, Liu YH, Absalon-Medina V, Hayrabedyan S, Todorova K, Gilbert RO, Guingab J, Barder TJ.

PLoS One. 2014 Jul 1;9(7):e100263. doi: 10.1371/journal.pone.0100263. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113886.

34.

Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.

Zhu J, Lin Z, Wu J, Yin H, Dai J, Feng Z, Marrero J, Lubman DM.

J Proteome Res. 2014 Jun 6;13(6):2986-97. doi: 10.1021/pr500128t. Epub 2014 May 7.

35.

Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.

Yin H, Lin Z, Nie S, Wu J, Tan Z, Zhu J, Dai J, Feng Z, Marrero J, Lubman DM.

J Proteome Res. 2014 Jun 6;13(6):2887-96. doi: 10.1021/pr500043k. Epub 2014 May 15.

36.

Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay.

Wu J, Zhu J, Yin H, Buckanovich RJ, Lubman DM.

J Proteome Res. 2014 Apr 4;13(4):2197-204. doi: 10.1021/pr401061c. Epub 2014 Mar 10.

37.

Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis.

Nie S, Lo A, Wu J, Zhu J, Tan Z, Simeone DM, Anderson MA, Shedden KA, Ruffin MT, Lubman DM.

J Proteome Res. 2014 Apr 4;13(4):1873-84. doi: 10.1021/pr400967x. Epub 2014 Mar 10.

38.

Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS.

Lin Z, Yin H, Lo A, Ruffin MT, Anderson MA, Simeone DM, Lubman DM.

Electrophoresis. 2014 Aug;35(15):2108-15. doi: 10.1002/elps.201300376. Epub 2013 Dec 27.

39.

Serum metabolomic analysis of pancreatic cancer--letter.

Shakour S, Ruffin MT, Zick SM, Lubman DM, Nie S.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1921. doi: 10.1158/1055-9965.EPI-13-0672. No abstract available.

40.

Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis.

Wu J, Xie X, Nie S, Buckanovich RJ, Lubman DM.

J Proteome Res. 2013 Jul 5;12(7):3342-52. doi: 10.1021/pr400169n. Epub 2013 Jun 17.

PMID:
23731285
41.

Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.

Zhu J, Nie S, Wu J, Lubman DM.

J Proteome Res. 2013 Jun 7;12(6):2791-804. doi: 10.1021/pr400139c. Epub 2013 May 29.

42.

Permethylated N-glycan analysis with mass spectrometry.

Lin Z, Lubman DM.

Methods Mol Biol. 2013;1007:289-300. doi: 10.1007/978-1-62703-392-3_12.

PMID:
23666731
43.

Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry.

Nie S, Lo A, Zhu J, Wu J, Ruffin MT, Lubman DM.

Anal Chem. 2013 Jun 4;85(11):5353-7. doi: 10.1021/ac400838s. Epub 2013 May 17.

44.

Analysis of glycoproteins for biomarker discovery.

He J, Liu Y, Wu J, Lubman DM.

Methods Mol Biol. 2013;1002:115-22. doi: 10.1007/978-1-62703-360-2_10.

45.

Immunohistochemical staining, laser capture microdissection, and filter-aided sample preparation-assisted proteomic analysis of target cell populations within tissue samples.

He J, Zhu J, Liu Y, Wu J, Nie S, Heth JA, Muraszko KM, Fan X, Lubman DM.

Electrophoresis. 2013 Jun;34(11):1627-36. doi: 10.1002/elps.201200566. Epub 2013 Apr 27.

46.

Characterization of membrane-associated glycoproteins using lectin affinity chromatography and mass spectrometry.

Liu Y, He J, Lubman DM.

Methods Mol Biol. 2013;951:69-77. doi: 10.1007/978-1-62703-146-2_6.

PMID:
23296525
47.

An N-glycosylation Analysis of Human Alpha-2-Macroglobulin Using an Integrated Approach.

Lin Z, Lo A, Simeone DM, Ruffin MT, Lubman DM.

J Proteomics Bioinform. 2012 May 31;5:127-134.

48.

Targeting glioblastoma stem cells: cell surface markers.

He J, Liu Y, Lubman DM.

Curr Med Chem. 2012;19(35):6050-5. Review.

PMID:
22963566
49.

Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.

Wu J, Xie X, Liu Y, He J, Benitez R, Buckanovich RJ, Lubman DM.

J Proteome Res. 2012 Sep 7;11(9):4541-52. doi: 10.1021/pr300330z. Epub 2012 Aug 6.

PMID:
22827608
50.

Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.

Zhu J, He J, Liu Y, Simeone DM, Lubman DM.

J Proteome Res. 2012 Apr 6;11(4):2272-81. doi: 10.1021/pr201059g. Epub 2012 Feb 28.

Supplemental Content

Loading ...
Support Center